| Bionomics Limited |
BNOX |
0% | -80% |
| Immix Biopharma Inc. |
IMMX |
5% | -68% |
| Genenta Science S.p.A. |
GNTA |
-3% | -3% |
| AN2 Therapeutics Inc. |
ANTX |
3% | -93% |
| Akanda Corp. |
AKAN |
0% | 0% |
| Akanda Corp. |
AKAN |
0% | 0% |
| Blue Water Vaccines Inc. |
BWV |
0% | -32% |
| Meihua International Medical Technologies Co. Ltd |
MHUA |
3% | -76% |
| ARCELLX Inc. |
ACLX |
3% | 38% |
| Nuvectis Pharma Inc. |
NVCT |
2% | -35% |
| Hillstream Biopharma Inc. |
HILS |
0% | 0% |
| Amylyx Pharmaceuticals Inc. |
AMLX |
10% | -74% |
| CinCor Pharma Inc. |
CINC |
0% | 0% |
| Vigil Neuroscience Inc. |
VIGL |
9% | -50% |
| Journey Medical Corporation |
DERM |
9% | -32% |
| Vaxxinity Inc. |
VAXX |
0% | -74% |
| IO Biotech Inc. |
IOBT |
-1% | -51% |
| Evotec SE |
EVO |
7% | -64% |
| MDxHEALTH SA |
MDXH |
0% | 0% |
| LianBio |
LIAN |
0% | -93% |
|
|
|
|
| Airsculpt Technologies Inc. |
AIRS |
13% | -31% |
| Aura Biosciences Inc. |
AURA |
2% | -7% |
| Entrada Therapeutics Inc. |
TRDA |
6% | 15% |
| Xilio Therapeutics Inc. |
XLO |
11% | 78% |
| Ventyx Biosciences Inc. |
VTYX |
13% | -11% |
| Context Therapeutics Inc. |
CNTX |
18% | 0% |
| MiNK Therapeutics Inc. |
INKT |
29% | -35% |
| Lucid Diagnostics Inc. |
LUCD |
-2% | -42% |
| Cognition Therapeutics Inc. |
CGTX |
7% | -62% |
| IsoPlexis Corp. |
ISO |
0% | 0% |
| Pyxis Oncology Inc. |
PYXS |
8% | -13% |
| THESEUS Pharmaceuticals Inc. |
THRX |
0% | 0% |
| Exscientia plc |
EXAI |
0% | -19% |
| CUE Health Inc. |
HLTH |
0% | -10% |
| DICE Therapeutics Inc. |
DICE |
0% | 0% |
| Tyra Biosciences Inc. |
TYRA |
12% | 0% |
| Eliem Therapeutics Inc. |
ELYM |
24% | -33% |
| Acumen Pharmaceuticals Inc. |
ABOS |
10% | -55% |
| Adagio Therapeutics Inc. |
ADGI |
0% | 0% |
| Immuneering Corp. |
IMRX |
7% | -70% |
|
|
|
|
| IN8bio Inc. |
INAB |
18% | 0% |
| Omega Therapeutics Inc. |
OMGA |
11% | -75% |
| Rani Therapeutics Holdings Inc. |
RANI |
12% | -59% |
| Tenaya Therapeutics Inc. |
TNYA |
6% | -56% |
| Icosavax Inc. |
ICVX |
0% | -3% |
| Nuvalent Inc. |
NUVL |
3% | 6% |
| Rallybio Corp. |
RLYB |
2% | -59% |
| Candel Therapeutics Inc. |
CADL |
6% | 490% |
| Cytek BioSciences Inc. |
CTKB |
5% | -29% |
| Sophia Genetics SA. |
SOPH |
10% | -37% |
| HCW Biologics Inc. |
HCWB |
3% | -65% |
| Erasca Inc. |
ERAS |
9% | 18% |
| Imago BioSciences Inc. |
IMGO |
0% | 0% |
| Regencell Bioscience Holdings Limited |
RGC |
1% | -46% |
| Stevanato Group S.p.A. |
STVN |
7% | -19% |
| TScan Therapeutics Inc. |
TCRX |
0% | -48% |
| Rapid Micro Biosystems Inc. |
RPID |
13% | 22% |
| Sera Prognostics INC. |
SERA |
-1% | 36% |
| Sight Sciences Inc. |
SGHT |
-4% | -29% |
| Transcode Therapeutics Inc. |
RNAZ |
0% | 0% |
|
|
|
|
| Aerovate Therapeutics Inc. |
AVTE |
1% | -88% |
| Acurx Pharmaceuticals LLC |
ACXP |
7% | -79% |
| Alpha Teknova Inc. |
TKNO |
4% | 123% |
| Elevation Oncology Inc. |
ELEV |
18% | 5% |
| GH Research PLC |
GHRS |
30% | 20% |
| Graphite Bio Inc. |
GRPH |
0% | 21% |
| Bright Health Group Inc. |
BHG |
0% | 0% |
| Miromatrix Medical Inc. |
MIRO |
0% | 0% |
| Monte Rosa Therapeutics Inc. |
GLUE |
3% | 23% |
| Ambrx Biopharma Inc. |
AMAM |
0% | 0% |
| ATAI Life Sciences B.V. |
ATA |
0% | 0% |
| Century Therapeutics Inc. |
IPSC |
9% | -70% |
| Codex DNA Inc. |
DNAY |
0% | -22% |
| Cyteir Therapeutics Inc. |
CYT |
0% | -1% |
| Femasys Inc. |
FEMY |
4% | 10% |
| iSpecimen Inc. |
ISPC |
0% | -45% |
| Lyell Immunopharma Inc. |
LYEL |
8% | -67% |
| Verve Therapeutics Inc. |
VERV |
11% | -60% |
| MOLECULAR PARTNERS AG |
MOLN |
7% | 20% |
| Alzamend Neuro Inc. |
ALZN |
0% | 0% |
|
|
|
|
| Janux Therapeutics Inc. |
JANX |
1% | 398% |
| Centessa Pharmaceuticals plc |
CNTA |
2% | 110% |
| Day One Biopharmaceuticals Holding Company LLC |
DAWN |
-1% | -13% |
| Singular Genomics Systems Inc. |
OMIC |
0% | -39% |
| Vera Therapeutics Inc. |
VERA |
2% | 175% |
| Flora Growth Corp. |
FLGC |
0% | 0% |
| Anebulo Pharmaceuticals Inc. |
ANEB |
-12% | -29% |
| Talaris Therapeutics Inc. |
TALS |
0% | 0% |
| Valneva SE |
VALN |
3% | -58% |
| Vaccitech plc |
VACC |
0% | 0% |
| Werewolf Therapeutics Inc. |
HOWL |
14% | -62% |
| Impel NeuroPharma Inc. |
IMPL |
0% | 0% |
| Rain Therapeutics Inc. |
RAIN |
0% | 1% |
| Treace Medical Concepts Inc. |
TMCI |
6% | -42% |
| NeuroPace Inc. |
NPCE |
4% | 9% |
| Zymergen Inc. |
ZY |
0% | 0% |
| Akoya Biosciences Inc. |
AKYA |
7% | -53% |
| Biomea Fusion Inc. |
BMEA |
-4% | -73% |
| Recursion Pharmaceuticals Inc. |
RXRX |
15% | -32% |
| Reneo Pharmaceuticals Inc. |
RPHM |
0% | -8% |
|
|
|
|
| Reneo Pharmaceuticals Inc. |
RPHM |
0% | -8% |
| VectivBio Holding AG |
VECT |
0% | 0% |
| Achilles Therapeutics plc |
ACHL |
-1% | 32% |
| Design Therapeutics Inc. |
DSGN |
8% | 133% |
| Edgewise Therapeutics Inc. |
EWTX |
4% | 144% |
| Ikena Oncology Inc. (formerly KYN Therapeutics) |
IKNA |
3% | -17% |
| LAVA Therapeutics BV |
LVTX |
9% | -39% |
| Olink Holding AB |
OLK |
0% | 1% |
| Movano Inc. |
MOVE |
0% | -57% |
| Finch Therapeutics Group Inc. |
FNCH |
0% | 0% |
| Instil Bio Inc. |
TIL |
0% | 0% |
| BriaCell Therapeutics Corp. |
BCTX |
0% | 0% |
| Virpax Pharmaceuticals Inc. |
VRPX |
0% | -3% |
| Decibel Therapeutics Inc. |
DBTX |
0% | 0% |
| Longeveron LLC |
LGVN |
0% | -75% |
| Talis Biomedical Corporation |
TLIS |
0% | 0% |
| Biophytis S.A. |
BPTS |
0% | 0% |
| Vallon Pharmaceuticals Inc. |
VLON |
0% | 0% |
| Evaxion Biotech A/S |
EVAX |
0% | -2% |
| Immunocore Holdings Limited |
IMCR |
1% | -57% |
|
|
|
|
| Cullinan Oncology LLC |
CGEM |
4% | 20% |
| Inhibikase Therapeutics Inc. |
IKT |
0% | 0% |
| 908 Devices Inc. |
MASS |
4% | -80% |
| BioAtla Inc. |
BCAB |
14% | -76% |
| 4D Molecular Therapeutic Inc. |
FDMT |
6% | -73% |
| Vivos Therapeutics Inc. |
VVOS |
0% | 0% |
| Seer Inc. |
SEER |
7% | 19% |
| Sigilon Therapeutics Inc. |
SGTX |
0% | 0% |
| Silverback Therapeutics Inc. |
SBTX |
0% | 0% |
| SQZ Biotechnologies Company |
SQZ |
0% | 0% |
| Abcam plc |
ABCM |
0% | 0% |
| Aligos Therapeutics Inc. |
ALGS |
0% | -43% |
| Kiromic Biopharma Inc. |
KRBP |
0% | 0% |
| PRAXIS PRECISION MEDICINES INC. |
PRAX |
0% | 0% |
| Aziyo Biologics Inc. |
AZYO |
-9% | 79% |
| Pulmonx Corp. |
LUNG |
-4% | -47% |
| Graybug Vision Inc. |
GRAY |
0% | 0% |
| Greenwich LifeSciences Inc. |
GLSI |
14% | 7% |
| PMV Pharmaceuticals Inc. |
PMVP |
3% | -51% |
| Prelude Therapeutics Incorporated |
PRLD |
8% | -70% |
|
|
|
|
| Taysha Gene Therapies Inc. |
TSHA |
10% | -2% |
| Athira Pharma Inc. |
ATHA |
-6% | -76% |
| COMPASS Pathways plc |
CMPS |
18% | -57% |
| American Well Corp. |
AMWL |
0% | -75% |
| Kymera Therapeutics Inc. |
KYMR |
3% | 58% |
| Nano-X Imaging Ltd. |
NNOX |
28% | 13% |
| Harmony Biosciences Holdings Inc. |
HRMY |
1% | 7% |
| Inhibrx Inc. |
INBX |
0% | -10% |
| Freeline Therapeutics Holdings plc |
FRLN |
0% | 0% |
| AlloVir Inc. |
ALVR |
5% | -38% |
| Annexon Inc. |
ANNX |
-2% | 13% |
| Inozyme Pharma Inc. |
INZY |
10% | -35% |
| iTeos Therapeutics Inc. |
ITOS |
6% | -30% |
| Nurix Therapeutics Inc. |
NRIX |
4% | 83% |
| Relay Therapeutics Inc. |
RLAY |
7% | -63% |
| Poseida Therapeutics Inc. |
PSTX |
-1% | 186% |
| Akouos Inc. |
AKUS |
0% | 0% |
| Fusion Pharmaceuticals Inc. |
FUSN |
0% | 122% |
| PolyPid Ltd. |
PYPD |
5% | -24% |
| Forma Therapeutics Holdings Inc. |
FMTX |
0% | 0% |
|
|
|
|
| Genetron Holdings Limited |
GTH |
0% | 0% |
| Repare Therapeutics inc. |
RPTX |
6% | -82% |
| Royalty Pharma plc |
RPRX |
1% | -9% |
| Avidity Biosciences Inc. |
RNA |
5% | 222% |
| Applied Molecular Transport Inc. |
AMTI |
0% | 0% |
| Pliant Therapeutics Inc. |
PLRX |
3% | -27% |
| Inari Medical Inc. |
NARI |
-3% | -21% |
| ADC Therapeutics SA |
ADCT |
1% | 20% |
| Ayala Pharmaceuticals Inc. |
AYLA |
0% | 0% |
| Lyra Therapeutics Inc. |
LYRA |
1% | -96% |
| ORIC Pharmaceuticals Inc. |
ORIC |
6% | -12% |
| Keros Therapeutics Inc. |
KROS |
-1% | -60% |
| Zentalis Pharmaceuticals LLC |
ZNTL |
7% | -80% |
| IMARA Inc. |
IMRA |
0% | 0% |
| Monopar Therapeutics Inc. |
MNPR |
0% | 121% |
| Revolution Medicines Inc. |
RVMD |
1% | 52% |
| Beam Therapeutics Inc. |
BEAM |
2% | -9% |
| Arcutis Biotherapeutics Inc. |
ARQT |
5% | 331% |
| Black Diamond Therapeutics Inc. |
BDTX |
3% | -24% |
| Annovis Bio Inc. |
ANVS |
8% | -73% |
|
|
|
|
| 89bio Inc. |
ETNB |
2% | -30% |
| CNS Pharmaceuticals Inc. |
CNSP |
0% | -84% |
| Galera Therapeutics Inc. |
GRTX |
0% | 32% |
| Oyster Point Pharma Inc. |
OYST |
0% | 0% |
| RAPT Therapeutics Inc. |
RAPT |
5% | -94% |
| Cabaletta Bio Inc. |
CABA |
5% | -90% |
| Phathom Pharmaceuticals Inc. |
PHAT |
-5% | -11% |
| TFF Pharmaceuticals Inc. |
TFFP |
0% | 0% |
| Innate Pharma SA |
IPHA |
4% | -36% |
| Vir Biotechnology Inc. |
VIR |
2% | -27% |
| BioNTech SE |
BNTX |
2% | 8% |
| Aprea Therapeutics Inc. |
APRE |
0% | 0% |
| Frequency Therapeutics Inc. |
FREQ |
0% | 0% |
| IGM Biosciences Inc. |
IGMS |
7% | -26% |
| Satsuma Pharmaceuticals Inc. |
STSA |
0% | 0% |
| SpringWorks Therapeutics Inc. |
SWTX |
6% | -1% |
| Castle Biosciences Inc. |
CSTL |
7% | 24% |
| Fulcrum Therapeutics Inc. |
FULC |
8% | -30% |
| Genmab A/S |
GMAB |
3% | -34% |
| Mirum Pharmaceuticals Inc. |
MIRM |
3% | 40% |
|
|
|
|
| Karuna Therapeutics Inc. |
KRTX |
0% | 4% |
| Xtant Medical Holdings Inc |
XTNT |
28% | 0% |
| Protalix BioTherapeutics Inc |
PLX |
14% | 0% |
| Cel Sci Corporation |
CVM |
7% | 0% |
| BioTime Inc |
BTX |
0% | 0% |
| Vericel Corporation |
VCEL |
4% | 54% |
| VBI Vaccines Inc |
VBIV |
0% | 0% |
| Vaxart Inc |
VXRT |
27% | 14% |
| Titan Pharmaceuticals Inc |
TTNP |
0% | 7% |
| Seattle Genetics Inc |
SGEN |
0% | 0% |
| Sangamo Therapeutics Inc |
SGMO |
30% | 86% |
| Repligen Corporation |
RGEN |
4% | -20% |
| Qiagen N.V. |
QGEN |
0% | 1% |
| PolarityTE Inc |
PTE |
0% | 0% |
| Pluristem Therapeutics Inc |
PSTI |
0% | 0% |
| Outlook Therapeutics Inc |
OTLK |
0% | -18% |
| Organovo Holdings Inc |
ONVO |
1% | -61% |
| Novavax Inc |
NVAX |
10% | 67% |
| Neurocrine Biosciences Inc |
NBIX |
1% | 4% |
| NanoString Technologies Inc |
NSTG |
0% | -86% |
|
|
|
|
| Moderna Inc |
MRNA |
1% | -58% |
| Microbot Medical Inc |
MBOT |
90% | -32% |
| Iovance Biotherapeutics Inc |
IOVA |
3% | -9% |
| Idera Pharmaceuticals Inc |
IDRA |
0% | 0% |
| Heska Corporation |
HSKA |
0% | 0% |
| Halozyme Therapeutics Inc |
HALO |
6% | 29% |
| Gilead Sciences Inc |
GILD |
-1% | 14% |
| Genetic Technologies Ltd |
GENE |
0% | 0% |
| Fennec Pharmaceuticals Inc |
FENC |
-3% | -44% |
| Fate Therapeutics Inc |
FATE |
9% | -56% |
| Erytech Pharma S A |
ERYP |
0% | 0% |
| Entera Bio Ltd |
ENTXW |
0% | 0% |
| Eiger BioPharmaceuticals Inc |
EIGR |
0% | -3% |
| CytRx Corporation |
CYTR |
0% | 0% |
| Curis Inc |
CRIS |
0% | 0% |
| Compugen Ltd |
CGEN |
5% | -23% |
| Champions Oncology Inc |
CSBR |
14% | 57% |
| CASI Pharmaceuticals Inc |
CASI |
0% | 0% |
| Brainstorm Cell Therapeutics Inc |
BCLI |
0% | 18% |
| bluebird bio Inc |
BLUE |
0% | -67% |
|
|
|
|
| Bio Techne Corp |
TECH |
3% | -7% |
| Biogen Inc |
BIIB |
-0% | -41% |
| BioCryst Pharmaceuticals Inc |
BCRX |
2% | 25% |
| argenx SE |
ARGX |
1% | 62% |
| Aptose Biosciences Inc |
APTO |
0% | 0% |
| Amgen Inc |
AMGN |
0% | -10% |
| Agenus Inc |
AGEN |
0% | -46% |
| Aerie Pharmaceuticals Inc |
AERI |
0% | 0% |
| Adverum Biotechnologies Inc |
ADVM |
0% | 102% |
| ADMA Biologics Inc |
ADMA |
7% | 279% |
| Acorda Therapeutics Inc |
ACOR |
0% | 0% |
| Solid Biosciences Inc. |
SLDB |
3% | -35% |
| Surface Oncology Inc. |
SURF |
0% | 0% |
| Scholar Rock Holding Corporation |
SRRK |
4% | 130% |
| MeiraGTx Holdings plc |
MGTX |
5% | -13% |
| AVROBIO Inc. |
AVRO |
0% | 4% |
| Autolus Therapeutics plc |
AUTL |
14% | -64% |
| Entera Bio Ltd. |
ENTX |
29% | 250% |
| Rubius Therapeutics Inc. |
RUBY |
0% | 0% |
| Replimune Group Inc. |
REPL |
4% | 44% |
|
|
|
|
| Liquidia Technologies Inc. |
LQDA |
4% | -2% |
| Sutro Biopharma Inc. |
STRO |
6% | -57% |
| Gritstone Oncology Inc. |
GRTS |
0% | -65% |
| Kodiak Sciences Inc |
KOD |
-8% | 228% |
| Allogene Therapeutics Inc. |
ALLO |
1% | -33% |
| LogicBio Therapeutics Inc. |
LOGC |
0% | 0% |
| Gamida Cell Ltd. |
GMDA |
0% | -89% |
| Twist Bioscience Corporation |
TWST |
4% | 26% |
| Orchard Therapeutics plc |
ORTX |
0% | 0% |
| Jounce Therapeutics Inc. |
JNCE |
0% | 0% |
| Krystal Biotech Inc. |
KRYS |
1% | 26% |
| Allena Pharmaceuticals Inc. |
ALNA |
0% | 0% |
| Denali Therapeutics Inc. |
DNLI |
4% | -5% |
| Editas Medicine Inc. |
EDIT |
4% | -87% |
| CRISPR Therapeutics AG |
CRSP |
4% | -37% |
| TRACON Pharmaceuticals Inc. |
TCON |
0% | -5% |
| Cellectis S.A. |
CLLS |
-8% | -41% |
| Cidara Therapeutics Inc. |
CDTX |
0% | -12% |
| Adaptimmune Therapeutics plc |
ADAP |
21% | -33% |
| aTyr Pharma Inc. |
LIFE |
10% | 157% |
|
|
|
|
| BiondVax Pharmaceuticals Ltd. |
BVXV |
0% | -26% |
| REGENXBIO Inc. |
RGNX |
1% | -57% |
| Voyager Therapeutics Inc. |
VYGR |
6% | -33% |
| Mesoblast Limited |
MESO |
0% | -5% |
| Genocea Biosciences Inc. |
GNCA |
0% | 0% |
| Applied Genetic Technologies Corporation |
AGTC |
0% | 0% |
| Atara Biotherapeutics Inc. |
ATRA |
0% | -23% |
| DBV Technologies S.A. |
DBVT |
0% | -40% |
| Coherus BioSciences Inc. |
CHRS |
21% | -59% |
